Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1149935

registered interest
date	16/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Essential Tremor: Magnetic Resonance Imagers
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans they have for the funding of MRI treatment of essential tremor following the recommendation by NICE for its use.
tabling member printed	Baroness Golding
uin	HL146
answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) published interventional procedure (IP) guidance on the use of Magnetic Resonance Imaging (MRI)-guided focused ultrasound as a treatment for essential tremor in June 2018. A copy of <em>Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor</em> is attached.</p><p>NICE concluded that the evidence on the safety of unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor raises no major safety concerns. However, current evidence on its efficacy is limited in quantity. Therefore, this procedure should not be used unless there are special arrangements for clinical governance, consent, and audit or research.</p><p>IP guidance looks at procedures used for diagnosis or treatment. It considers if they are safe and work well enough for wider use in the National Health Service. Whilst compliance with IP guidance is not mandatory, it is considered best clinical practice for the NHS to take it into account.</p> answering member printed Baroness Blackwood of North Oxford question first answered 25/10/2019 10:19:11 answering member 4019 label Biography information for Baroness Blackwood of North Oxford attachment 1 file name MRI-essential-tremor.pdf title MRI-essential-tremor
tabling member	281 label Biography information for Baroness Golding

1149806

registered interest
date	15/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alcoholic Drinks: Misuse
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the publication of the Prevention green paper in July, what steps they plan to take to address and prevent alcohol harm.
tabling member printed	Baroness Hayter of Kentish Town
uin	HL98
answer	answer is ministerial correction date of answer 29/10/2019 answer text <p>The Government is committed to tackling health harms from alcohol and to support the most vulnerable at risk from alcohol misuse. The Prevention Green Paper <em>Advancing our health: prevention in the 2020s</em> outlines how we will help people moderate their drinking by working with industry to deliver a significant increase in the availability of alcohol-free and low-alcohol products by 2025. The Government will engage with industry and other stakeholders around delivering this objective.</p><p>Lower socioeconomic status is associated with higher mortality for alcohol-attributable causes, despite lower socioeconomic groups often reporting lower levels of consumption. As part of the NHS Long Term Plan, we are establishing specialist Alcohol Care Teams in hospitals with the highest rates of alcohol harm. It is estimated that this will prevent 50,000 admissions over five years. Local authorities will also receive over £3 billion in 2019/20 to be used exclusively on public health including alcohol treatment services. Public Health England is supporting NHS England’s tobacco and alcohol commissioning for quality and innovation scheme, which encourages hospitals to screen all inpatients about their alcohol use and offer appropriate interventions.</p><p>The UK Chief Medical Officers issued Low Risk Drinking Guidelines in 2016 so that people could make informed choices about their own drinking and the Government has worked with industry to ensure information on the health harms of alcohol are printed clearly on the labelling of alcoholic drinks.</p><p>The Government has also made funding of £6 million available to support children who live with an alcohol dependent parent which will address the inequalities facing this vulnerable group.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL101 HL99 question first answered 29/10/2019 15:50:45 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4159 label Biography information for Baroness Hayter of Kentish Town

1149809

registered interest
date	15/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alcoholic Drinks: Misuse
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they are taking to prevent alcohol harm and reduce health inequalities.
tabling member printed	Baroness Hayter of Kentish Town
uin	HL101
answer	answer is ministerial correction date of answer 29/10/2019 answer text <p>The Government is committed to tackling health harms from alcohol and to support the most vulnerable at risk from alcohol misuse. The Prevention Green Paper <em>Advancing our health: prevention in the 2020s</em> outlines how we will help people moderate their drinking by working with industry to deliver a significant increase in the availability of alcohol-free and low-alcohol products by 2025. The Government will engage with industry and other stakeholders around delivering this objective.</p><p>Lower socioeconomic status is associated with higher mortality for alcohol-attributable causes, despite lower socioeconomic groups often reporting lower levels of consumption. As part of the NHS Long Term Plan, we are establishing specialist Alcohol Care Teams in hospitals with the highest rates of alcohol harm. It is estimated that this will prevent 50,000 admissions over five years. Local authorities will also receive over £3 billion in 2019/20 to be used exclusively on public health including alcohol treatment services. Public Health England is supporting NHS England’s tobacco and alcohol commissioning for quality and innovation scheme, which encourages hospitals to screen all inpatients about their alcohol use and offer appropriate interventions.</p><p>The UK Chief Medical Officers issued Low Risk Drinking Guidelines in 2016 so that people could make informed choices about their own drinking and the Government has worked with industry to ensure information on the health harms of alcohol are printed clearly on the labelling of alcoholic drinks.</p><p>The Government has also made funding of £6 million available to support children who live with an alcohol dependent parent which will address the inequalities facing this vulnerable group.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL98 HL99 question first answered 29/10/2019 15:50:45 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4159 label Biography information for Baroness Hayter of Kentish Town

1149712

registered interest
date	14/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fertility: Medical Treatments
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the impact of the judgment in R (TT) v the Registrar General for England and Wales & Ors [2019] EWHC 2384 (Fam) on the (1) Human Fertilisation and Embryology Act 2008, and (2) regulation of fertility treatment by the Human Fertilisation and Embryology Authority.
tabling member printed	Baroness Barker
uin	HL5
answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>The Court found that the scheme of birth registration for the children of trans men is lawful and proportionate. The Government welcomes the Court’s decision.</p><p>The Government’s view is that the judgment has no effect on the availability of regulated fertility treatment and will now consider whether there should be further guidance to clarify this position. The Government considers that regulated fertility treatment is currently, and will remain, equally available to all (trans) women and (trans) men under the Human Fertilisation and Embryology Acts.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL6 question first answered 25/10/2019 11:54:37 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2501 label Biography information for Baroness Barker

1149713

registered interest
date	14/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fertility: Medical Treatments
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the impact of the judgment in R (TT) v the Registrar General for England and Wales & Ors [2019] EWHC 2384 (Fam) on members of the trans community who wish to access fertility treatment at a licensed clinic.
tabling member printed	Baroness Barker
uin	HL6
answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>The Court found that the scheme of birth registration for the children of trans men is lawful and proportionate. The Government welcomes the Court’s decision.</p><p>The Government’s view is that the judgment has no effect on the availability of regulated fertility treatment and will now consider whether there should be further guidance to clarify this position. The Government considers that regulated fertility treatment is currently, and will remain, equally available to all (trans) women and (trans) men under the Human Fertilisation and Embryology Acts.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL5 question first answered 25/10/2019 11:54:37 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2501 label Biography information for Baroness Barker

1149714

registered interest
date	14/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Capacity: Codes of Practice
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government when consultation on the Code of Practice issued under the Mental Capacity (Amendment) Act 2019 will commence.
tabling member printed	Baroness Barker
uin	HL7
answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>Following Royal Assent for the Mental Capacity (Amendment) Act 2019, the Department has been engaging across England and Wales with a range of key stakeholders from the health and social care sector and people with lived experience to co-produce the Code of Practice for the new Liberty Protection Safeguards. We plan to start public consultation in the new year and the Code will be laid before both Houses ahead of the new Liberty Protection Safeguards system coming into force.</p> answering member printed Baroness Blackwood of North Oxford question first answered 25/10/2019 11:55:05 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2501 label Biography information for Baroness Barker

1149751

registered interest
date	14/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vancomycin
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what information they hold on the availability of Vancomycin for the treatment of Clostridium difficile in pharmacies across the country.
tabling member printed	Baroness Masham of Ilton
uin	HL44
answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>The Department fully understands that maintaining access to vancomycin for the treatment of Clostridium difficile is vitally important to many people in this country.</p><p>We are aware that two manufacturers of vancomycin capsules are currently experiencing supply issues. However, alternative manufacturers have supplies available and there are sufficient supplies available to continue to meet normal United Kingdom demand.</p><p>We continue to work closely with industry and partners in the health system to help prevent shortages and to ensure that the risks to patients are minimised when supply issues do arise.</p> answering member printed Baroness Blackwood of North Oxford question first answered 25/10/2019 12:07:42 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1850 label Biography information for Baroness Masham of Ilton

1149756

registered interest
date	14/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Eating Disorders: Mental Health Services
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, following their response to the Seventeenth Report of Session 2017–19 by the House of Commons Public Administration and Constitutional Affairs Committee (HC855) on 23 September, how many sites have been selected to "pump prime" innovative models of service for adults with eating disorders; and where those test sites will be.
tabling member printed	Baroness Parminter
uin	HL49
answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>NHS England and NHS Improvement are providing ‘pump prime’ funding to 12 pilot sites over 2019/20 and 2020/21 to test and implement new models of integrated primary and community mental health care for adults and older adults with a range of severe mental illnesses. Eight of these will test models that include services for adult eating disorders, including:</p><p>- Cambridgeshire and Peterborough Sustainability and Transformation Partnership;</p><p>- Cheshire and Merseyside Sustainability and Transformation Partnership;</p><p>- Herefordshire and Worcestershire Sustainability and Transformation Partnership;</p><p>- Hertfordshire and West Essex Sustainability and Transformation Partnership;</p><p>- North East London Sustainability and Transformation Partnership;</p><p>- North West London Sustainability and Transformation Partnership;</p><p>- Somerset Sustainability and Transformation Partnership; and</p><p>- South Yorkshire and Bassetlaw Integrated Care System</p><p>These sites will work towards improving access to care for adults and older adults with eating disorders in line with published guidance from NHS England and NHS Improvement. They will also generate the first phase of learning about how to achieve greater levels of parity with children and young people’s eating disorder services over the course of the NHS Long Term Plan.</p> answering member printed Baroness Blackwood of North Oxford question first answered 25/10/2019 11:55:40 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4178 label Biography information for Baroness Parminter

1149763

registered interest
date	14/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: British Nationals Abroad
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they intend to take to ensure the provision of healthcare for UK pensioners living in the European Union post-Brexit.
tabling member printed	Lord Taylor of Warwick
uin	HL56
answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>The Government is committed to securing a deal with the European Union and is working in an energetic and determined way to achieve this.</p><p>The United Kingdom Government has proposed to all Member States that we should maintain existing reciprocal healthcare arrangements, including the S1 scheme, until 31 December 2020 if the UK leaves the EU without a deal. These arrangements would safeguard healthcare for the hundreds of thousands of UK-insured persons who live in Europe.</p><p>I laid a Written Ministerial Statement (HLWS1795) on 26 September 2019, setting out the Department’s progress on ‘no deal’ reciprocal healthcare arrangements, and updated information has been published online on the situation for each Member State, including what arrangements have been put in place. These pages will be kept updated as further assurances from Member States are received.</p> answering member printed Baroness Blackwood of North Oxford question first answered 25/10/2019 12:07:26 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1796 label Biography information for Lord Taylor of Warwick

1149773

registered interest
date	14/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bevacizumab
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government why Avastin is not routinely made available on the NHS for certain groups of cancer patients.
tabling member printed	Lord Willis of Knaresborough
uin	HL66
answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>Most new medicines are assessed by the National Institute for Health and Care Excellence (NICE) which makes recommendations for the National Health Service on whether they represent a clinically and cost effective use of NHS resources. Since 2016, NICE makes recommendations for the NHS on all new licensed cancer medicines through its technology appraisal programme. NHS commissioners are legally required to fund treatments recommended in NICE technology appraisal guidance.</p><p>NICE has appraised Avastin (bevacizumab) for use in the treatment of a number of different types of cancer and has unfortunately not been able to recommend it as a clinically and cost effective use of NHS resources for any type of cancer at the price offered by the drug company. Avastin is not therefore routinely funded by the NHS for any licensed indication.</p><p>Avastin is funded as an off-label treatment for some types of cancer through the Cancer Drugs Fund.</p> answering member printed Baroness Blackwood of North Oxford question first answered 25/10/2019 11:56:13 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4151 label Biography information for Lord Willis of Knaresborough